Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Gastrointestinal 4Breast 4Thoracic 3Genitourinary 3Other hematologic neoplasm 2Head & Neck 2Tumor-Agnostic 1Other 1Myeloid 1Gynecologic 1Endocrine 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 3Pain 1Inflammation 1Breast Diseases 1Agnosia 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Ibuprofen × Breast × Clear all
NCT02463383 2017-12-12

EPPNASE

University of Copenhagen

Phase EARLY_PHASE1 Completed
25 enrolled
Breast

Breast Neoplasms

NCT02461056 2015-06-03

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Samsung Medical Center

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown
1,568 enrolled
Breast

Breast Neoplasms, Inflammation

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed
150 enrolled
Breast

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡